IQVIA Holdings Inc.


SKU: IQV Category:


IQVIA Holdings:  Industry Tailwinds: Rising EBP Funding and Traction in Oncology Space! 


IQVIA displayed a strong performance in the fourth quarter of 2023. CEO Ari Bousbib highlighted that net new bookings for the quarter exceeded $2.8 billion, marking the second largest quarter in the company’s history. The business booked $10.7 billion of net new business in the year, including record-high service bookings of $8.4 billion. These achievements indicate a robust demand from its Research & Development Solutions (R&DS) clients, contributing to a solid financial performance.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!